β-Amyloid protein aggregation: Its implication in the physiopathology of Alzheimer's disease

Pathologie Biologie

Volumn 49, Issue 1, 2001, Pages 72-85

  Dumery, L ^a   Bourdel, F ^a   Soussan, Y ^a   Fialkowsky, A ^a   Viale, S ^a   Nicolas, P ^b   Reboud Ravaux, M ^b  

^a SORBONNE UNIVERSITÉ   (France)

^b INSTITUT JACQUES MONOD   (France)

Author keywords

Aggregation; Alzheimer's disease; Amyloid deposit; A peptide; Inhibitor; Oxidative stress

Indexed keywords

AMYLOID BETA PROTEIN; FREE RADICAL;

ALZHEIMER DISEASE; FIBER; HUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PROTEIN CONFORMATION; PROTEIN DEGRADATION; PROTEIN PROCESSING; PROTEIN SYNTHESIS; REVIEW;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; AMYLOID BETA-PROTEIN PRECURSOR; ENDOPEPTIDASES; HUMANS; MODELS, MOLECULAR; NEUROFIBRILS; OXIDATIVE STRESS; PROTEIN CONFORMATION;

EID: 0035110620     PISSN: 03698114     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0369-8114(00)00009-2     Document Type: Review

References (76)

1. The amyloid precursor protein gene: A neuropeptide gene with diverse functions in the central nervous system
2. Cellular actions of β-amyloid precursor protein and its soluble and fibrillogenic derivatives
3. Role of amyloid precursor protein in the mechanisms of neurodegeneration in Alzheimer's disease
4. Expression of V642 APP mutant causes cellular apoptosis as Alzheimer trait-linked phenotype
5. Amyloid precursor protein, copper and Alzheimer's disease
6. Cholinergic activity and amyloid precursor protein metabolism
7. Interaction between the zinc (II) and the heparin binding site of the Alzheimer's disease βA4 amyloid precursor protein (APP)
8. β-Secretase cleavage of Alzheimer's amyloid precursor protein by transmembrane aspartic acid BACE
9. Identification of a novel aspartic protease (Asp 2) as β-secretase
10. The role of APP processing and trafficking pathway in the formation of amyloid β-protein
11. Amyloid, the presenilins and Alzheimer's disease
12. Differences between vascular and plaque core amyloid in Alzheimer's disease
13. Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein
14. Empirical predictions of protein conformation
15. Aggregation and secondary structure of synthetic amyloid β-A4 peptides of Alzheimer's disease
16. Nicotinic receptor stimulation protects neurons against beta-amyloid toxicity
17. Structural determinants of the Alzheimer's amyloid β-peptide
18. Solution structures of β-peptide and its constituent fragments: Relation to amyloid deposition
19. Solution conformations and aggregational properties of synthetic amyloid β-peptides of Alzheimer's disease
20. Solution structure of amyloid β-peptide (1-40) in a water-micelle environment. Is the membrane-spanning domain where we think it is?
21. Interaction of Alzheimer's β-amyloid peptide (1-40) with lipid membranes
22. The carboxyterminus of the β-amyloid protein is critical for the seeding of amyloid formation: Implications for the pathogenesis of Alzheimer's disease
23. The alphahelical to beta-strand transition in the amino-terminal fragment of the amyloid beta-peptide modulates amyloid formation
24. Assembly of A beta amyloid protofibrils: An in vitro model for a possible early event in Alzheimer's disease
25. Structural and kinetic features of amyloid β-protein fibrillogenesis
26. Substitutions of hydrophobic amino acids reduce the amyloidogenicity of the Alzheimer's disease βA4 peptides
27. Selective inhibition of A-beta fibril formation
28. Effects of β-protein mutations on amyloid fibril nucleation and elongation
29. Morphology and antibody recognition of synthetic β-amyloid peptides
30. Fibril formation by primate, rodent, and Dutch-hemorrhagic analogues of Alzheimer amyloid β-protein
31. pH-dependent structural transitions of Alzheimer amyloid peptides
32. Conformation and fibrillogenesis of Alzheimer Aβ peptides with selected substitution of charged residues
33. Presenile dementia and cerebral haemorrhage linked to a mutation at codon 692 of the β-amyloid precursor protein gene
34. Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrahge, Dutch-type
35. Full-length amyloid-β(1-42[43]) and amino-terminally modified and truncated amyloid-β42(43) deposit in diffuse plaques
36. Isolation, chemical characterization, and quantitation of Aβ-3-pyroglutamyl peptide from neuritic plaques and vascular amyloid deposits
37. Structural alterations in the peptide backbone of β-amyloid core protein may account for its deposition and stability in Alzheimer's disease
38. Amino- and caboxy-terminal heterogeneity of β-amyloid peptides deposited in human brain
39. Oxidative mechanism in beta-amyloid cytotoxicity
40. Amyloid β-protein toxicity and oxidative stress in Alzheimer's disease
41. Molecular determinants of amyloid deposition in Alzheimer's disease: Conformational studies of synthetic β-protein fragments
42. Proinfammatory profile of cytokine production by human monocytes and murine microglia stimulated with β-amyloid [25-35]
43. Amino-terminal deletions enhance aggregation of β-amyloid peptides in vitro
44. 2+ channels provides a mechanism for neuronal death in Alzheimer's disease
45. Alzheimer's peptide A beta 1-42 binds two beta-sheet of alpha I-antichymotrypsin and transforms it from inhibitor to substrate
46. Assembly and aggregation properties of synthetic Alzheimer's A4/β amyloid peptide analogs
47. Selective aggregation of endogenous β-amyloid peptide and soluble amyloid precursor protein in cerebrospinal fluid by zinc
48. Racemization of Asp 23 residue affects the aggregation properties of Alzheimer amyloid beta-protein analogues
49. Acetylcholinesterase promotes the aggregation of amyloid-beta-peptide fragments by forming a complex with the growing fibrils
50. Relative efficacies of amyloid beta peptide (A beta) binding proteins in A beta aggregation
51. Multivalent binding of complement protein C1Q to the amyloid beta-peptide (A beta) promotes the nucleation phase of A beta aggregation
52. Nacp, the precursor protein of the non-amyloid beta/A4 protein (A-beta) component of Alzheimer disease amyloid, binds A-beta and stimulates A-beta aggregation
53. Heparin-binding properties of the amyloidogenic peptides A-beta and amylin
54. Hemin and related porphyrins inhibit beta-amyloid aggregation
55. Alpha 2-macroglobulin attenuates beta-amyloid peptide 1-40 fibril formation and associated neurotoxicity of cultured fetal rat cortical neurons
56. Neurite-promoting effect of alpha 2-macroglobulin in rat cerebral cortex is mainly associated with alpha 2-macroglobulin receptor
57. Alpha 2-macroglobulin is an astroglia-derived neurite-promoting factor for cultured neurons from rat central nervous system
58. Clusterin (ApoJ) alters the aggregation of amyloid beta peptide (1-42) and forms slowly sedimenting A beta complexes that causes oxidative stress
59. Beta-cyclodextrin interacts with the Alzheimer amyloid beta-A4 peptide
60. Inhibition of amyloid beta protein aggregation and neurotoxicity by rifampicin. Its possible function as a hydroxyl radical scavenger
61. Binding of the protease-sensitive form of PrP (prion protein) to sulfated glycosaminoglycan and Congo red
62. Congo red inhibition of scrapie agent replication
63. Potent inhibition of scrapie-associated PrP accumulation by Congo red
64. Beta-amyloid neurotoxicity requires fibril formation and is inhibited by Congo red
65. A lipophilic analogue of Congo red, inhibits A beta-induced toxicity in PC12 cells
66. Sulfonated dyes attenuate the toxic effects of beta-amyloid in a structure-specific fashion
67. Nicotine inhibits amyloid formation by the beta peptide
68. Soluble multimeric Alzheimer beta (1-40) pre-amyloid complexes in dilute solution
69. The conformation of Alzheimer's beta peptide determines the rate of amyloid formation and its resistance to proteolysis
70. Concentration-dependent inhibitory effects of apolipoprotein E on Alzheimer's β-amyloid fibril formation in vitro
71. Zinc induced aggregation of human and rat beta-amyloid peptides in vitro
72. Metal cations defibrillize the amyloid beta-protein fibrils
73. A strategy for designing inhibitors or β-amyloid toxicity
74. The structure of amyloid fibrils by electron microscopy and X-ray diffraction
75. Amyloid fibrils may be assembled from β-helical protofibrils